Since their beginnings in 1986, UCT has evolved into a major competitor in the field of silica based solid phase extraction technology. The first to pioneer commercially available ‘mixed-mode’ SPE products, 30 years later UCT is still optimizing sample analysis for forensic, pharmaceutical, clinical, environmental and agricultural laboratories. Michael J. Telepchak, founder and CEO UCT, Inc., has laid the foundation for this powerful technology and has truly served as a catalyst for its transformation from a novel technique to an industry gold standard. From fundamental chemistry to manufacturing and business development, he has bared witness to all facets of the evolution of solid phase extraction and will speak on the monumental impact it has made on the scientific community.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.